Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Rang in Aktien #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Aktienkurs
$1.02
Marktkapitalisierung
$131.45M
Veränderung (1 Tag)
-0.62%
Veränderung (1 Jahr)
-37.92%
Land
TW
Handel Pharmosa Biopharm Inc. (6875)

Kategorie

Dividendenrendite-Verlauf für Pharmosa Biopharm Inc. (6875)
Dividendenrendite (TTM) von Pharmosa Biopharm Inc. (Aktienkürzel: 6875) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Pharmosa Biopharm Inc. (6875) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH